Novartis (NVS) said Wednesday that it won't raise its $45-a-share price for a majority of Chiron (CHIR), the Emeryville, Calif., maker of vaccines, drugs and blood-testing products.
The Swiss drug company was responding to a letter that ValueAct Capital, an investment management firm in San Francisco, sent to Chiron, saying the offer was too low. ValueAct, the owner of about 5% of Chiron's stock, says it will vote against the Novartis offer. Novartis is seeking to buy the 56% of Chiron's shares that it doesn't own. The company made a $40-a-share bid in September, but Chiron's board rejected the proposal. In late October, Novartis raised the price. The Federal Trade Commission has approved the transaction. The companies need clearance from the European Union and a majority of Chiron shares, excluding those owned by Novartis. Get Jim Cramer's picks for 2006.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,858.71 | 1,351.56 | 2,925.37 | 19.84 |
Oil *
118.13
|
|
UP
57.48 |
UP
8.92 |
UP
21.49 |
UP
0.15 |
10 Yr
1.98%
SPDR Gold
166.99
|
|
+0.45%
|
+0.66%
|
+0.74%
|
+0.76%
|
Data delayed 20 minutes |
Connect with TheStreet